KTTA

Pasithea Therapeutics Corp. KTTA

KTTA
Pasithea Therapeutics Corp. QNRX
Quoin Pharmaceuticals, Ltd. IBO
Impact BioMedical Inc. KALA
KALA BIO, Inc. AIM
AIM ImmunoTech Inc. TCRT
Alaunos Therapeutics, Inc. VYNE
VYNE Therapeutics Inc. VIVS
VivoSim Labs, Inc. CYCN
Cyclerion Therapeutics, Inc. PLRZ
Polyrizon Ltd.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode KTTA QNRX IBO KALA AIM TCRT VYNE VIVS CYCN PLRZ
6M 47.06 % 58.85 % 22.56 % -85.68 % -85.23 % -7.23 % -34.28 % 32.19 % -50.17 % 131.35 %
YTD -62.46 % -41.24 % -71.18 % -92.50 % -93.82 % 102.03 % -82.44 % 12.21 % -55.32 % -99.63 %
1Y -58.80 % -38.98 % -73.43 % -90.36 % -92.84 % 97.03 % -75.53 % 12.21 % -50.17 % -99.71 %
3Y -92.67 % -97.75 % -83.44 % -85.50 % -95.88 % -95.13 % -80.31 % 12.21 % -87.95 % -99.57 %
5Y -98.46 % -99.97 % -83.44 % -99.84 % -99.38 % -99.05 % -99.56 % 12.21 % -97.75 % -99.57 %
10Y -98.46 % -100.00 % -83.44 % -99.94 % -99.97 % -99.68 % -99.97 % 12.21 % -99.41 % -99.57 %
Depuis le début -98.46 % -100.00 % -83.44 % -99.94 % -85.16 % -99.83 % -99.97 % 12.21 % -99.41 % -99.57 %

Dividende